Fort Pitt Capital Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,286
Closed -$205K 180
2018
Q3
$205K Buy
+2,286
New +$202K 0.01% 135
2018
Q2
Sell
-2,668
Closed -$238K 147
2018
Q1
$238K Buy
+2,668
New +$256K 0.02% 117
2017
Q4
Sell
-2,276
Closed -$332K 132
2017
Q3
$332K Buy
2,276
+351
+18% +$47.8K 0.03% 91
2017
Q2
$250K Buy
1,925
+11
+0.6% +$1.35K 0.02% 102
2017
Q1
$238K Buy
+1,914
New +$229K 0.02% 100

Other funds holding CELG

Fort Pitt Capital Group's CELG Position: Q4 2018 in Review

Fort Pitt Capital Group sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,286 shares — an estimated $205K sold.

Fort Pitt Capital Group first reported a position in CELG in Q1 2017 and held it in 5 quarters. The position peaked at $332K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Fort Pitt Capital Group reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Fort Pitt Capital Group sold 2,286 Celgene Corp shares in Q4 2018, an estimated $205K.
  • Fort Pitt Capital Group first reported a position in Celgene Corp in Q1 2017 and held it in 5 quarters.
  • Fort Pitt Capital Group's Celgene Corp position peaked at $332K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Fort Pitt Capital Group's 13F filing for Q4 2018, filed 6 Feb 2019.